Frix, A N <br/><br/>
Effectiveness of omalizumab on patient reported outcomes, lung function, and inflammatory markers in severe allergic asthma.  [electronic resource] 

 -  Biochemical pharmacology  09 2020 
 - 113944 p.  digital 
<br/><br/> Publication Type: Journal Article; Observational Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1873-2968 
<br/><br/><label>Standard No.: </label>10.1016/j.bcp.2020.113944  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Anti-Allergic Agents--therapeutic use<br/>Anti-Asthmatic Agents--therapeutic use<br/>Asthma--drug therapy<br/>Female<br/>Humans<br/>Lung--drug effects<br/>Male<br/>Middle Aged<br/>Omalizumab--therapeutic use<br/>Quality of Life<br/>Retrospective Studies<br/>Treatment Outcome